Aura Health Completes Name Change to Pharmadrug Inc

Aura Health (CSE: BUZZ) announced this morning that it has completed its name change to that of Pharmadrug Inc. The name change is intended to better reflect the operations of the firm, whom is focused on importing quality medical cannabis to the German and other European markets.

The name change, which was proposed earlier this year via a circular issued to shareholders, was approved on October 3 at an annual and special meeting of shareholders. The change reflects Aura’s 80% purchase of Pharmadrug Production GmbH this past may, a firm with the necessary narcotics licensing to import cannabis and other medical products to the German state.

We are consistently working to further develop our distribution of medical cannabis in Germany. In addition to the continued expansion of volumes from The Netherlands Office of Medicinal Cannabis, we are to launch our own proprietary brand with the introduction of Israeli-sourced supply in the second half of 2020. The company also expects upcoming Canadian supply deals, which could lead to an earlier ramp and brand launch.

Daniel Cohen, CEO of Pharmadrug

Common shares of Aura Health held by shareholders will automatically exchange for shares of Pharmadrug, without investors being required to take any action. There was no indication by the firm that the associated ticker would be changing.

Aura Health, now Pharmadrug, closed Friday’s session at $0.04.


FULL DISCLOSURE: Pharmadrug is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pharmadrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

This Is Why Copper Could Explode Next | Ian Harris – Copper Giant

This Is What $3,300 Gold Unlocks | Tara Christie – Banyan Gold

Real Gold Bull Market Energy Is Back | Matthew Roma – Golden Cross

Recommended

Discovery Silver in Advanced Talks to Acquire Barrick’s Last Canadian Gold Mine

Emerita Reports Aznalcollar Public Tender Trial Hearings Have Concluded, Verdict Expected This Fall

Related News

PharmaDrug Engages Research Lab To Advance Patented Cocaine Synthesis Method

PharmaDrug (CSE: PHRX) has formally engaged a research lab to refine and advance the development...
Tuesday, April 16, 2024, 09:31:23 AM

PharmaDrug Anticipates Biosynthetic Cocaine Commercial-Scale Production In As Little As 12 Months

PharmaDrug Inc (CSE: PHRX) has established a strategic plan to push forward with its intent...
Monday, May 13, 2024, 08:55:00 AM

Aura Health Signs 5-Year Israeli Supply Agreement

Aura Health (CSE: BUZZ) announced this morning that it has signed its first supply agreement...

Thursday, September 19, 2019, 09:52:07 AM

Canopy Growth’s Bruce Linton Finds Himself in a Catch-22

Canopy Growth Corp’s (TSX: WEED) (NYSE: CGC) Bruce Linton came under fire yesterday across social...

Friday, June 28, 2019, 09:22:46 AM

Is Cocaine Turning The Tide Towards Legalization?

Switzerland is currently reevaluating its stance on drug policy as reports emerge of a groundbreaking...
Wednesday, March 20, 2024, 10:40:00 AM